Related references
Note: Only part of the references are listed.Proteomics of brain, CSF, and plasma identifies molecular signatures for distinguishing sporadic and genetic Alzheimer's disease
Yun Ju Sung et al.
SCIENCE TRANSLATIONAL MEDICINE (2023)
Impact of increased APP gene dose in Down syndrome and the Dp16 mouse model
Mariko Sawa et al.
ALZHEIMERS & DEMENTIA (2022)
Microglial efferocytosis: Diving into the Alzheimer's disease gene pool
Carmen Romero-Molina et al.
NEURON (2022)
Association of Apolipoprotein E ε4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down Syndrome
Alexandre Bejanin et al.
JAMA NEUROLOGY (2021)
Evaluation of the National Task Group-Early Detection Screen for Dementia: Sensitivity to 'mild cognitive impairment' in adults with Down syndrome
Wayne Silverman et al.
JOURNAL OF APPLIED RESEARCH IN INTELLECTUAL DISABILITIES (2021)
Differential Associations of Apolipoprotein E ε4 Genotype With Attentional Abilities Across the Life Span of Individuals With Down Syndrome
Hana D'Souza et al.
JAMA NETWORK OPEN (2020)
The Alzheimer's Biomarker Consortium-Down Syndrome: Rationale and methodology
Benjamin L. Handen et al.
ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2020)
Longitudinal assessment of dementia measures in Down syndrome
Lisa Koehl et al.
ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2020)
Promising outcome measures of early Alzheimer's dementia in adults with Down syndrome
Sharon J. Krinsky-McHale et al.
ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2020)
The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer's disease risk
Yuetiva Deming et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Association of Dementia With Mortality Among Adults With Down Syndrome Older Than 35 Years
Rosalyn Hithersay et al.
JAMA NEUROLOGY (2019)
Polygenic risk score of sporadic late-onset Alzheimer's disease reveals a shared architecture with the familial and early-onset forms
Carlos Cruchaga et al.
ALZHEIMERS & DEMENTIA (2018)
The discovery of Alzheimer-causing mutations in the APP gene and the formulation of the amyloid cascade hypothesis
John Hardy
FEBS JOURNAL (2017)
The Link between Alzheimer's Disease and Down Syndrome. A Historical Perspective
Ahmad Salehi et al.
CURRENT ALZHEIMER RESEARCH (2016)
The Cellular Phase of Alzheimer's Disease
Bart De Strooper et al.
CELL (2016)
Common polygenic variation enhances risk prediction for Alzheimer's disease
Valentina Escott-Price et al.
BRAIN (2015)
A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome
Frances K. Wiseman et al.
NATURE REVIEWS NEUROSCIENCE (2015)
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Chia-Chan Liu et al.
NATURE REVIEWS NEUROLOGY (2013)
Association of variants within APOE, SORL1, RUNX1, BACE1 and ALDH18A1 with dementia in Alzheimer's disease in subjects with Down syndrome
Ashok Patel et al.
NEUROSCIENCE LETTERS (2011)
Analyses of the National Institute on Aging Late-Onset Alzheimer's Disease Family Study Implication of Additional Loci
Joseph H. Lee et al.
ARCHIVES OF NEUROLOGY (2008)
Significant effect of APOE Epsilon 4 Genotype on the risk of dementia in Alzheimer's disease and mortality in persons with Down Syndrome
V. P. Prasher et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2008)
Apolipoprotein e genotypic frequencies among down syndrome patients imply early unsuccessful aging for ApoE4 carriers
Giusi I. Forte et al.
REJUVENATION RESEARCH (2007)
Dementia screening questionnaire for individuals with intellectual disabilities
Shoumitro Deb et al.
BRITISH JOURNAL OF PSYCHIATRY (2007)
APOE ε4 influences the manifestation of Alzheimer's disease in adults with Down's syndrome
S Deb et al.
BRITISH JOURNAL OF PSYCHIATRY (2000)
Share Paper
